STAT

JULY 3, 2023

When the U.S. Supreme Court released its landmark ruling overturning the use of race-conscious college admissions, LaShyra Nolen was on clinical rotation. For Nolen, a fourth-year medical student at Harvard Medical School, the news sent a chill down her spine even though she had been anticipating it. “It felt very lonely,” said Nolen, who is Black and the first in her family to get a bachelors of science degree and attend medical school.

Medical Schools 285

Medical Schools 285

PharmaVoice

JULY 3, 2023

From staff shortages to presidential candidates and the M&A outlook, here are our most-read stories from the first half of the year.

130

130

STAT

JULY 3, 2023

DENVER — The founder of Field Trip , a chain of shuttered ketamine clinics currently facing insolvency, put forward an unexpected theory of how psychedelics work to treat depression last month. “The truth is, almost all of the effect of psychedelic-assisted therapy could be placebo,” said Ronan Levy, speaking at a five-day conference on the emerging field of psychedelic medicine.

254

254

Pharma Times

JULY 3, 2023

Project aims to boost the adoption of technology across London’s NHS and help patients manage conditions - News - PharmaTimes

153

153

Speaker: Chris Antypas and Josh Halladay

Access to limited distribution drugs and payer contracts are key to pharmacy expansion. But how do you prepare your operations to take the next step? Meaningful data: Collect and share clinical data regarding outcomes, utilization, and more Reporting: Limited distribution models require efficient tracking and reporting systems Workflows: Align workflows with specific pharma and payer contractual requirements For in-depth, expert insights on pharmacy expansion, watch this webinar from Inovalon.

STAT

JULY 3, 2023

Here is STAT’s biotech scorecard, our regular ledger of stock-moving biotech events, for the third quarter: Novo Nordisk is conducting a large clinical trial to prove that its GLP-1 drug Wegovy, in addition to helping people lose weight, also improves cardiovascular health. The SELECT study enrolled 17,500 participants who had overweight or obesity and had preexisting heart disease.

Hospitals 226

Hospitals 226

Pharmaceutical Technology

JULY 3, 2023

Pipeline developments within the obesity space have recently garnered interest following recent results published on Eli Lilly’s retatrutide.

119

119

The Pharmacist

JULY 3, 2023

NHS England will work with the General Medical Council (GMC) to allow pharmacists and some other healthcare professionals to train as medics under a shortened medical degree programme, it has been announced. This would be possible due to the UK’s position outside the European Union, which provides greater flexibility to recognise prior learning and experience […] The post Pharmacists could train as medics under new shortened degree appeared first on The Pharmacist.

93

93

STAT

JULY 3, 2023

For years, diabetes tech company Dexcom has been striving to get its continuous glucose monitors into the hands of type 2 diabetes patients. Last week at the American Diabetes Association’s conference, the company unveiled plans for software built entirely for these patients, including ones who don’t take insulin. “We’ve been so focused on things that match the needs of somebody who manages diabetes every minute of every day, and insulin delivery,” Kevin Sayer,

Diabetes 191

Diabetes 191

The Pharmacist

JULY 3, 2023

Integrated Care Systems (ICSs) should work with community pharmacy to improve interoperability and data sharing within and between systems, the Health and Social Care Committee (HSCC) has recommended. In its eighth report on digital transformation in the NHS, published on Friday (30 June), the HSCC drew attention to the ‘slow progress’ and lack of clarity […] The post Parliamentary committee highlights ‘slow progress’ on community pharmacy IT appeared first on The Pharmacist.

Community Pharmacies 92

Community Pharmacies 92

STAT

JULY 3, 2023

Five years from now, when patients walk into a doctor’s office presenting symptoms of almost any condition you can envision — whether migraine, multiple sclerosis, or obesity — their physician will offer a new kind of treatment plan that involves both pharmaceutical-based medication and a prescription digital therapeutic. Accessible through the patient’s smartphone, the digital therapeutic will deliver personalized, evidence-based interventions to treat their conditio

183

183

Advertisement

Are you still using workarounds to manage your daily operations? To achieve peak performance, it's time to explore other options for specialty and infusion pharmacy software. Streamline pharmacy operations and improve clinical performance with automated processing, real-time data exchange, and electronic decision support. Download this helpful infographic to: Drive efficiency and patient adherence from referral receipt to delivery and ongoing care – all with our Pharmacy Cloud.

Pharmacy Management

Express Pharma

JULY 3, 2023

Anupam Rasayan , a custom synthesis and speciality chemicals manufacturer, inks Memorandum of Understanding (MoU) with 3xper Innoventure, a subsidiary of Tube Investments of India for supply of targeted and identified new age pharma molecules. The identified products for Active Pharmaceutical Ingredients (API) will be developed under the CRAMS and CDMO models.

90

90

The Pharmacist

JULY 3, 2023

The risk of anaemia is higher among patients aged 70 years and older taking a daily dose of 100 mg of enteric-coated aspirin, according to a post hoc analysis of the ASPREE randomised controlled trial. The Aspirin in Reducing Events in the Elderly (ASPREE) trial was designed to examine whether a daily dose of 100 mg of […] The post Daily aspirin increases anaemia risk among elderly appeared first on The Pharmacist.

89

89

European Pharmaceutical Review

JULY 3, 2023

Positive topline data has been revealed from the pivotal ELATIVE ® Phase III trial of elafibranor , an investigational dual α,δ PPAR agonist for primary biliary cholangitis (PBC). Data showed 51 percent of patients on 80mg of the small molecule treatment elafibranor achieved a cholestasis response compared with four percent on placebo. The Phase III trial enrolled 161 patients.

87

87

Pharmaceutical Technology

JULY 3, 2023

2023 started with a buzz around ChatGPT, and more generally around the immense potential that generative AI (GenAI) holds.

105

105

Pharma Times

JULY 3, 2023

The therapy becomes an option for moderate-to-severe plaque psoriasis in certain adults - News - PharmaTimes

102

102

Pharmaceutical Technology

JULY 3, 2023

China has granted approval for Innovent Biologics and IASO Bio Fucaso for treating relapsed or refractory multiple myeloma (RRMM) in adults.

97

97

BioPharma Dive

JULY 3, 2023

What is the GDPR and why does it matter to your life sciences company. iliomad Health Data can help you maintain GDPR compliance.

98

98

Pharmaceutical Technology

JULY 3, 2023

Madrigal Pharmaceuticals has commenced a rolling submission of an NDA seeking expedited approval from the US FDA for resmetirom.

98

98

Outsourcing Pharma

JULY 3, 2023

George Freeman MP, minister of state at the new Department for Science, Innovation and Technology, has praised a decade of growth at Discovery Park, the leading science and innovation campus in Sandwich, Kent.

98

98

Express Pharma

JULY 3, 2023

Credit Analysis & Research has reaffirmed IOL Chemicals and Pharmaceuticals’ long-term Rating to ‘ A+’ with a stable outlook. The company’s short term rating has been reaffirmed to A1+. A company release stated, “CARE’s reaffirmation of IOL’s ratings underscores the company’s consistent track record of delivering high-quality products and its commitment to maintaining strong financial stability.

78

78

Outsourcing Pharma

JULY 3, 2023

RAIR Health, an applied data and AI company focused on the extraction of clinical insights from real world data, has signed a non-exclusive data license agreement with Royal Cornwall Hospitals NHS Trust (RCH) focussed on the field of ophthalmology.

Hospitals 98

Hospitals 98

Express Pharma

JULY 3, 2023

Biocon Biologics, a subsidiary of Biocon, announced that HULIO (adalimumab-fkjp) injection, a biosimilar to Humira (adalimumab), is available to patients in the US. “ The launch of HULIO, our biosimilar adalimumab, in the US is an important milestone for Biocon Biologics as it expands our well-known biosimilar product offering to patients in the United States,” said Shreehas Tambe, CEO & MD, Biocon Biologics. “ Biocon Biologics is pleased to make HULIO, a patient-friendly, two-click, prefill

Biosimilars 75

Biosimilars 75

Pharmaceutical Technology

JULY 3, 2023

The bioscience company has received $10m Series A financing from asset manager Mercia.

97

97

Express Pharma

JULY 3, 2023

How is the industry’s approach to drug development transforming? What are the imperatives that led to this change? How is Waters aiding advancements in drug development? A central aim in drug development is to create new molecular entities into commercially viable drugs useful in managing diseases. While there are significant obstacles to marketing new drugs, the past 15 years have shown an increase in the number of drug approvals.

Biosimilars 75

Biosimilars Drug Development Generic Medicine Diabetes 75

The Guardian - Pharmaceutical Industry

JULY 3, 2023

Shares close down 8% on concerns that new lung cancer drug may not be as successful as hoped Nearly £14bn has been wiped off the stock market value of AstraZeneca over concerns that a new lung cancer drug may not be as successful as had been hoped. Shares in the Anglo-Swedish pharmaceutical company closed down 8% on Monday after it published the first results from its phase 3 trial for datopotamab deruxtecan, making it the biggest faller among FTSE 100 companies.

Pharmaceutical Companies 70

Pharmaceutical Companies Pharmaceutical Companies 70

Outsourcing Pharma

JULY 3, 2023

Kicking off a series of DIA Global interviews in Boston, OSP had the pleasure of speaking to Cal Collins, co-founder and CEO of OpenClinica - a company that wants to empower data managers, clinical researchers, and study participants.

92

92

pharmaphorum

JULY 3, 2023

Australia first to prescribe MDMA and psilocybin for depression, PTSD Nicole.

93

93

World Pharma News

JULY 3, 2023

Artificial intelligence can predict on- and off-target activity of CRISPR tools that target RNA instead of DNA, according to new research published in Nature Biotechnology. The study by researchers at New York University, Columbia Engineering, and the New York Genome Center, combines a deep learning model with CRISPR screens to control the expression of human genes in different ways - such as flicking a light switch to shut them off completely or by using a dimmer knob to partially turn down the

64

64

pharmaphorum

JULY 3, 2023

AZ, Daiichi’s TROP2 drug hits the mark in lung cancer Phil.

96

96

Pharmafile

JULY 3, 2023

Reacta Healthcare, an early-stage food allergy diagnostic company, has announced the appointment of Kevin Hawkins as head of regulatory affairs. Hawkins has extensive leadership experience including in R&D, regulatory affairs, analytical development and project leadership, having previously worked as senior director and head of development at Teva Pharmaceuticals for more than ten years.

52

52

pharmaphorum

JULY 3, 2023

Don't hold back lab digital transformation Mike.

98

98

Pharmafile

JULY 3, 2023

The Helmholtz Centre for Infection Research (HZI), Germany, has appointed Professor Josef Penninger as scientific director. Penninger has previously worked as founding director at the Institute for Molecular Biotechnology of the Austrian Academy of Sciences, Vienna, Austria; professor at the Department of Medical Genetics at the University of British Columbia, Canada; and director of the […] The post Josef Penninger appointed as new scientific director of Helmholtz Centre for Infection Res

52

52

Drug Patent Watch

JULY 3, 2023

[![posaconazole structure]([link] Posaconazole is the generic ingredient in three branded drugs marketed by Msd Merck Co, Merck Sharp Dohme, Par Sterile Products, Schering, Hikma, Actavis Labs Fl Inc, Aet Pharma,… The post New tentative approval for Mylan Labs drug posaconazole appeared first on DrugPatentWatch - Make Better Decisions.

52

52

Digital Pharmacist

JULY 3, 2023

As a pharmacy owner, safeguarding your business from potential risks is crucial. One effective way to mitigate these risks is by having comprehensive insurance coverage. Determining the coverage needs and evaluating insurance requirements for your pharmacy can ensure you’re adequately protected in the face of any unforeseen circumstances. Risk Accessing Your Pharmacy Before diving into insurance options, it’s essential to understand the risks specific to your pharmacy.

Insurance Coverage and Processing 52

Insurance Coverage and Processing Prescription Filling 52

Drug Patent Watch

JULY 3, 2023

LEVITRA (vardenafil hydrochloride) Bayer hlthcare Patent: 8,841,446 Expiration: Jul 3, 2023 See More … For more information on how DrugPatentWatch can help with your pharmaceutical business intelligence needs, contact admin@DrugPatentWatch.com… The post Drug Patent Expirations for the Week of July 2, 2023 appeared first on DrugPatentWatch - Make Better Decisions.

52

52